Melissa Wasserstein, M.D. is the Chief of the Division of Pediatric Genetic Medicine at the Children’s Hospital at Montefiore and an Associate Professor of Pediatric and Genetics at the Albert Einstein College of Medicine (AECOM). Dr. Wasserstein received her B.S. in biology from Cornell University and her medical degree from New York University School of Medicine. She completed her pediatrics residency and medical genetics fellowship at the Mount Sinai School of Medicine, where she subsequently remained as a faculty member before moving to Einstein-Montefiore in 2016.
In addition to diagnosing and managing patients with inborn errors of metabolism, Dr. Wasserstein is a clinical investigator. Her research focuses on expanding newborn screening for rare inherited disorders and evaluating the associated ethical, legal and social implications. She is a Principal Investigator of NYCKidSeq, a multisite NHGRI and NIMHD funded program studying the implementation of genomic medicine in underserved populations. She has been the Principal Investigator on numerous clinical trials evaluating novel therapeutics for rare genetic diseases.
Dr. Wasserstein is a Co-Chair of the Newborn Screening Translational Research Network’s Steering Committee. She is on the Executive Committee of AECOM’s Rose F. Kennedy Intellectual and Developmental Disabilities Research Center where she also serves as Associate Director of the Human Clinical Phenotyping Core. In addition, she is on the Scientific Advisory Boards of the International Niemann-Pick Disease Association, the MSUD family support group, and WylderNation.